Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors
- PMID: 2078283
Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors
Abstract
The hallucinogenic agent d-lysergic acid diethylamide (d-LSD) interacts with a number of serotonin (5-hydroxytryptamine [5-HT]) receptor subtypes in the central nervous system. It has been hypothesized that hallucinosis is produced by agonist activity at 5-HT2 receptors. There exist, however, numerous data from radioligand binding, cellular, smooth muscle, and behavioral studies that suggest that d-LSD is a potent 5-HT2 antagonist. These data are reviewed in this report. In addition, d-LSD displays agonist activity at 5-HT1A and 5-HT1C receptor subtypes, as determined in biochemical studies. At the present time, agonist interactions at 5-HT1C receptors, as opposed to 5-HT2 receptors, appears to be a more likely "common mechanism of action" of hallucinogenic agents.
Similar articles
-
Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.J Pharmacol Exp Ther. 1988 Dec;247(3):918-25. J Pharmacol Exp Ther. 1988. PMID: 3204523
-
Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.Mol Pharmacol. 1992 Nov;42(5):826-30. Mol Pharmacol. 1992. PMID: 1359397
-
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.Psychopharmacology (Berl). 1988;94(2):213-6. doi: 10.1007/BF00176847. Psychopharmacology (Berl). 1988. PMID: 3127847
-
Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).Neuropsychopharmacology. 1999 Aug;21(2 Suppl):77S-81S. doi: 10.1016/S0893-133X(99)00005-6. Neuropsychopharmacology. 1999. PMID: 10432492 Review.
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
Cited by
-
Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.Neuropharmacology. 2011 Sep;61(3):348-54. doi: 10.1016/j.neuropharm.2011.01.012. Epub 2011 Feb 1. Neuropharmacology. 2011. PMID: 21288474 Free PMC article.
-
4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes.Br J Pharmacol. 2004 Apr;141(7):1167-74. doi: 10.1038/sj.bjp.0705722. Epub 2004 Mar 8. Br J Pharmacol. 2004. PMID: 15006903 Free PMC article.
-
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures.Molecules. 2024 Feb 22;29(5):964. doi: 10.3390/molecules29050964. Molecules. 2024. PMID: 38474476 Free PMC article. Review.
-
Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists.Psychopharmacology (Berl). 1995 Aug;120(4):384-91. doi: 10.1007/BF02245809. Psychopharmacology (Berl). 1995. PMID: 8539318
-
Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus.J Neurosci. 2015 Mar 18;35(11):4540-51. doi: 10.1523/JNEUROSCI.4825-14.2015. J Neurosci. 2015. PMID: 25788672 Free PMC article.